Initial [18F]DCFPyL PET/CT in treatment-naïve prostate cancer: correlation with post-ADT PSA outcomes and recurrence.
Yuekai LiShiwei WangShimin ZhaoPengfei ZhaoShuai HuangKaiyue LiShaoli HanCaixia TianXin LiBenkang ShiXiang LiPublished in: European journal of nuclear medicine and molecular imaging (2024)
Our study revealed that pretreatment [18F]DCFPyL uptake in primary or metastatic tumor sites is prognostically relevant in high-risk PCa patients undergoing ADT. Further research is needed to develop robust predictive models in this multifaceted landscape of PCa management.